| Literature DB >> 26628296 |
Abstract
Gliomas are derived from astroglial precursors or astrocytes, accounting for 40 % central nervous system tumors. MicroRNAs (miRNAs) are a class of endogenous, small (19- to 23-nucleotides) non-coding RNAs involved in cancer progression. Recent studies show that circulating miRNAs are associated with the clinicopathological features and prognosis of gliomas. Serum miRNAs may serve as novel biomarkers for gliomas diagnosis. This review explores the possibilities of using serum miRNAs as prognostic, diagnostic markers, and therapeutic targets in gliomas.Entities:
Keywords: Biomarkers; Circulating miRNAs; Gliomas; MicroRNA; Serum miRNAs
Mesh:
Substances:
Year: 2015 PMID: 26628296 DOI: 10.1007/s13277-015-4515-7
Source DB: PubMed Journal: Tumour Biol ISSN: 1010-4283